Inhibition of virally induced TFEB proteasomal degradation as a host-centric therapeutic approach for coronaviral infection
Science Advances · 06.06.2025 · 11 (23)
DOI: 10.1126/sciadv.adv4033 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 06.06.2025. Verfasst von Travis B Lear und 26 weiteren Autor:innen. Beteiligte Einrichtung: Aging Institute, University of Pittsburgh/UPMC, Pittsburgh, PA 15219, USA. Hauptthemen laut MEDLINE: Proteasome Endopeptidase Complex, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors, SARS-CoV-2, Antiviral Agents. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NHLBI NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
The endolysosomal pathway plays an evolutionarily conserved role in pathogen clearance, and viruses have evolved complex mechanisms to evade this host defense system. Here, we describe a previously unidentified aspect of coronaviral infection, whereby the master transcriptional activator of lysosomal homeostasis—TFEB—is targeted for proteasomal-mediated degradation upon viral infection. Through mass spectrometry analysis and an unbiased small interfering RNA screen, we identify that TFEB protein stability is coordinately regulated by the E3 ubiquitin ligase subunit DCAF7 and the PAK2 kinase. We derive a series of novel small molecules that interfere with the DCAF7-TFEB interaction. These agents inhibit virus-induced TFEB degradation and demonstrate broad antiviral activities including attenuating severe acute respiratory syndrome coronavirus 2 infection in two animal models. Together, these results delineate a virally triggered pathway that impairs lysosomal homeostasis in the host. Small molecule E3 ubiquitin ligase DCAF7 inhibitors that restore lysosomal function represent a novel class of host-directed, antiviral therapies useful for current and potentially future coronaviral variants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Aging Institute, University of Pittsburgh/UPMC, Pittsburgh, PA 15219, USA.
- Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, PA 15213, USA.
- Department of Infectious Diseases and Microbiology, School of Public Health, University of Pittsburgh, Pittsburgh, PA 15213, USA.
- Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA 15213, USA.
- Department of Cell Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA.
- Center for Biologic Imaging, University of Pittsburgh School of Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA.
ORCID-Profile: Travis B Lear, Mads B Larsen, Bo Lin, Benjamin R Treat, Qing Cao, Áine N Boudreau, Irene Alfaras, Daniel P Camarco, Yao Tong, Jay X Tan, John J Villandre, Yanwen Chen, Claudette St Croix, Yusuke Sekine, John W Evankovich, Simon M Barratt-Boyes, Toren Finkel, Bill B Chen, Yuan Liu
Förderung
- NIA NIH HHS
- NHLBI NIH HHS
- NIAID NIH HHS
Zitieren
APA
Lear, T. B., Larsen, M. B., Lin, B., Treat, B. R., Cao, Q., Boudreau, Á. N., Lockwood, K. C., Alfaras, I., Kennerdell, J. R., Salminen, L., Camarco, D. P., Tong, Y., Ma, J., Liu, J., Tan, J. X., Tuncer, F., Villandre, J. J., Hertzel, L., Myerburg, M. M., …, & Liu, Y. (2025). Inhibition of virally induced TFEB proteasomal degradation as a host-centric therapeutic approach for coronaviral infection. Science Advances, 11(23). https://doi.org/10.1126/sciadv.adv4033
Vancouver
Lear TB, Larsen MB, Lin B, Treat BR, Cao Q, Boudreau ÁN, et al. Inhibition of virally induced TFEB proteasomal degradation as a host-centric therapeutic approach for coronaviral infection. Science Advances. 2025;11(23). doi:10.1126/sciadv.adv4033
BibTeX
@article{Lear2025,
author = {Lear, Travis B and Larsen, Mads B and Lin, Bo and Treat, Benjamin R and Cao, Qing and Boudreau, Áine N and Lockwood, Karina C and Alfaras, Irene and Kennerdell, Jason R and Salminen, Laura and Camarco, Daniel P and Tong, Yao and Ma, Jing and Liu, Jie and Tan, Jay X and Tuncer, Ferhan and Villandre, John J and Hertzel, Lucas and Myerburg, Michael M and Chen, Yanwen and St Croix, Claudette and Sekine, Yusuke and Evankovich, John W and Barratt-Boyes, Simon M and Finkel, Toren and Chen, Bill B and Liu, Yuan},
title = {Inhibition of virally induced TFEB proteasomal degradation as a host-centric therapeutic approach for coronaviral infection},
journal = {Science Advances},
year = {2025},
volume = {11},
number = {23},
doi = {10.1126/sciadv.adv4033}
}
EUVIMED